1-10 of 10
Vincenzo Cassibba
Close
Sort by
Journal Articles

Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)

Renato Bassan, MD, Arianna Masciulli, PharmD, Tamara Intermesoli, MD, Orietta Spinelli, PhD, Manuela Tosi, PhD, Chiara Pavoni, MSc, Ernesta Audisio, MD, Giuseppe Rossi, MD, Monica Fumagalli, MD, Vincenzo Cassibba, MD, Daniele Mattei, MD, Claudio Romani, MD, Agostino Cortelezzi, MD, Fabio Ciceri, MD, Anna Maria Scattolin, MD, Umberto Vitolo, MD, Erika Borlenghi, MD, Sergio Cortelazzo, MD, Andrea Gallamini, MD, Lorella Depaoli, MD, Leonardo Campiotti, MD, Monica Tajana, MD, Monica Bocchia, MD, Antonella Vitale, MD, Marco Ladetto, MD, Eros Di Bona, MD, Elena Oldani, BiolSc, Alessandro Rambaldi, MD
Journal: Blood
Blood (2016) 128 (22): 176.
https://doi.org/10.1182/blood.V128.22.176.176
Published: 2016
Journal Articles

Phase II Randomized Trial Of Radiation-Free Central Nervous System (CNS) Prophylaxis Comparing Intrathecal Triple Therapy With Liposomal Cytarabine (DepoCyte ® ) In Adult Acute Lymphoblastic Leukemia (ALL)

Renato Bassan, MD, Arianna Masciulli, BiolSc, Tamara Intermesoli, MD, Ernesta Audisio, MD, Chiara Cattaneo, MD, Enrico Maria Pogliani, MD, Vincenzo Cassibba, MD, Daniele Mattei, MD, Claudio Romani, MD, Agostino Cortelezzi, MD, Consuelo Corti, MD, Anna Maria Scattolin, MD, Orietta Spinelli, BiolSC, Manuela Tosi, BiolSC, Margherita Parolini, MD, Filippo Marmont, MD, Erika Borlenghi, MD, Monica Fumagalli, MD, Sergio Cortelazzo, MD, Andrea Gallamini, MD, Rosa Maria Marfisi, Elena Oldani, BiolSC, Roberto Marchioli, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2013) 122 (21): 3901.
https://doi.org/10.1182/blood.V122.21.3901.3901
Published: 2013
Journal Articles

Long-Term Health Related Quality Of Life and Symptom Burden In Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid (ATRA) and Chemotherapy

Fabio Efficace, Alessandro Rambaldi, MD, Eros Di Bona, MD, Francesco Fabbiano, MD, Francesco Cottone, Massimo Breccia, Giuseppe Avvisati, MD, PhD, Robin Foà, Monica Morselli, MD, Ilaria Cutini, Elena Rossetti, MD, Pietro Leoni, Brunangelo Falini, Claudio Romani, MD, Francesco Di Raimondo, MD, Valentina Mancini, Stefano D'Ardia, MD, Giovanni Martinelli, MD, Vincenzo Cassibba, MD, Olimpia Finizio, Nicola Cascavilla, Angelo Michele Carella, Marco Vignetti, Franco Mandelli, MD, Francesco Lo Coco, MD
Journal: Blood
Blood (2013) 122 (21): 770.
https://doi.org/10.1182/blood.V122.21.770.770
Published: 2013
Journal Articles

High Cure Rates in Burkitt Leukemia and Lymphoma: NILG Study of the German Short Intensive Rituximab-Chemotherapy Program

Tamara Intermesoli, MD, Alessandro Rambaldi, MD, Chiara Cattaneo, MD, Federica Delaini, BiolSC, Claudio Romani, MD, Enrico Maria Pogliani, MD, Chiara Pagani, MD, Emanuele Angelucci, MD, Elisabetta Terruzzi, MD, Alessandro Levis, MD, Vincenzo Cassibba, MD, Daniele Mattei, MD, Giacomo Gianfaldoni, MD, Anna Maria Scattolin, MD, Eros Di Bona, MD, Elena Oldani, BiolSC, Margherita Parolini, MD, Nicola Gokbuget, MD, Dieter Hoelzer, MD, Renato Bassan, MD
Journal: Blood
Blood (2012) 120 (21): 1494.
https://doi.org/10.1182/blood.V120.21.1494.1494
Published: 2012
Journal Articles

In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Imatinib (IM) and Chemotherapy in Combination Improve Remission Rate, Stem Cell Transplantation Rate and Long-Term Outcome

Tamara Intermesoli, MD, Chiara Cattaneo, MD, Enrico Maria Pogliani, MD, Eros Di Bona, MD, Claudio Romani, MD, Vincenzo Cassibba, MD, Agostino Cortelezzi, MD, Francesco Mannelli, MD, Fabio Ciceri, MD, Daniele Mattei, MD, Orietta Spinelli, BiolSC, Manuela Tosi, BiolSC, Elena Oldani, BiolSC, Alessandro Rambaldi, MD, Renato Bassan, MD
Journal: Blood
Blood (2012) 120 (21): 662.
https://doi.org/10.1182/blood.V120.21.662.662
Published: 2012
Journal Articles

Early Response Dynamics Including Minimal Residual Disease (MRD) and Adherence to Risk/MRD-Oriented Therapy Are Major Outcome Determinants in Adult Ph-Negative Acute Lymphoblastic Leukemia (ALL).

Renato Bassan, MD, Orietta Spinelli, BiolSC, Elena Oldani, BiolSC, Manuela Tosi, BiolSC, Barbara Peruta, BiolSC, Erika Borlenghi, MD, Enrico Maria Pogliani, MD, Eros Di Bona, MD, Vincenzo Cassibba, MD, Anna Maria Scattolin, MD, Claudio Romani, MD, Fabio Ciceri, MD, Agostino Cortelezzi, MD, Giacomo Gianfaldoni, MD, Daniele Mattei, MD, Ernesta Audisio, MD, Tamara Intermesoli, Alessandro Rambaldi, MD
Journal: Blood
Blood (2012) 120 (21): 2573.
https://doi.org/10.1182/blood.V120.21.2573.2573
Published: 2012
Journal Articles

In Adult Acute Lymphoblastic Leukemia (ALL) Different Minimal Residual Disease (MRD) Levels Predict Clinical Outcome in All Patients and Response to Allogeneic/Autologous Transplantation in MRD-Positive Patients.

Renato Bassan, MD, Orietta Spinelli, BiolSC, Elena Oldani, BiolSC, Manuela Tosi, BiolSC, Barbara Peruta, BiolSC, Erika Borlenghi, MD, Enrico Maria Pogliani, MD, Eros Di Bona, MD, Vincenzo Cassibba, MD, Anna Maria Scattolin, MD, Claudio Romani, MD, Fabio Ciceri, MD, Agostino Cortelezzi, MD, Giacomo Gianfaldoni, MD, Daniele Mattei, MD, Ernesta Audisio, MD, Tamara Intermesoli, Alessandro Rambaldi, MD
Journal: Blood
Blood (2012) 120 (21): 2493.
https://doi.org/10.1182/blood.V120.21.2493.2493
Published: 2012
Journal Articles

Pediatric-Type Therapy Including Lineage-Targeted Methotrexate to Improve Early Minimal Residual Disease Response and Survival In Adult Acute Lymphoblastic Leukemia (ALL): Interim Analysis of Northern Italy Leukemia Group Study 10/07

Renato Bassan, Tamara Intermesoli, Arianna Masciulli, Giuseppe Rossi, Enrico Maria Pogliani, Orietta Spinelli, Giorgio Lambertenghi-Deliliers, Ernesta Audisio, Daniele Mattei, Fabio Ciceri, Vincenzo Cassibba, Claudio Romani, Eros Di Bona, Alessandro Levis, Manuela Tosi, Barbara Peruta, Margherita Parolini, Erika Borlenghi, Monica Fumagalli, Federica Delaini, Rosa Maria Marfisi, Elena Oldani, Roberto Marchioli, Alessandro Rambaldi
Journal: Blood
Blood (2010) 116 (21): 2131.
https://doi.org/10.1182/blood.V116.21.2131.2131
Published: 2010
Journal Articles

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Clinical Trials & Observations
Renato Bassan, Orietta Spinelli, Elena Oldani, Tamara Intermesoli, Manuela Tosi, Barbara Peruta, Giuseppe Rossi, Erika Borlenghi, Enrico M. Pogliani, Elisabetta Terruzzi, Pietro Fabris, Vincenzo Cassibba, Giorgio Lambertenghi-Deliliers, Agostino Cortelezzi, Alberto Bosi, Giacomo Gianfaldoni, Fabio Ciceri, Massimo Bernardi, Andrea Gallamini, Daniele Mattei, Eros Di Bona, Claudio Romani, Anna Maria Scattolin, Tiziano Barbui, Alessandro Rambaldi
Journal: Blood
Blood (2009) 113 (18): 4153–4162.
https://doi.org/10.1182/blood-2008-11-185132
Published: 2009
Includes: Supplemental data
Journal Articles

Impact of Prophylaxis with Aerosolized Amphotericin-B Deoxycholate (d-AmB) on Respiratory Tract Invasive Fungal Infections (IFIs) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Enrico Morello, MD, Irene M. Cavattoni, M.D., Pietro Fabris, M.D., Silvia Coin, B.S.C., Barbara Amato, M.D., Vincenzo Cassibba, M.D., Marco Casini, M.D., Leonardo Pagani, M.D., Sergio Cortelazzo, M.D.
Journal: Blood
Blood (2007) 110 (11): 4986.
https://doi.org/10.1182/blood.V110.11.4986.4986
Published: 2007